Browse hierarchy: [Neurology (NE)](/submissions/NE) → [Subpart F — Neurological Therapeutic Devices](/submissions/NE/subpart-f%E2%80%94neurological-therapeutic-devices) → [21 CFR 882.5830](/submissions/NE/subpart-f%E2%80%94neurological-therapeutic-devices/882.5830) → GZE — Implanted Diaphragmatic/Phrenic Nerve Stimulator

# GZE · Implanted Diaphragmatic/Phrenic Nerve Stimulator

_Neurology · 21 CFR 882.5830 · Class 3_

**Canonical URL:** https://fda.innolitics.com/submissions/NE/subpart-f%E2%80%94neurological-therapeutic-devices/GZE

## Overview

- **Product Code:** GZE
- **Device Name:** Implanted Diaphragmatic/Phrenic Nerve Stimulator
- **Regulation:** [21 CFR 882.5830](/submissions/NE/subpart-f%E2%80%94neurological-therapeutic-devices/882.5830)
- **Device Class:** 3
- **Review Panel:** [Neurology](/submissions/NE)
- **Implant:** yes

## Identification

An implanted diaphragmatic/phrenic nerve stimulator is a device that provides electrical stimulation of a patient's phrenic nerve to contract the diaphragm rhythmically and produce breathing in patients who have hypoventilation (a state in which an abnormally low amount of air enters the lungs) caused by brain stem disease, high cervical spinal cord injury, or chronic lung disease. The stimulator consists of an implanted receiver with electrodes that are placed around the patient's phrenic nerve and an external transmitter for transmitting the stimulating pulses across the patient's skin to the implanted receiver.

## Classification Rationale

Class III (premarket approval).

## Recent Cleared Devices (1 of 1)

| Record | Device Name | Applicant | Decision Date | Decision |
| --- | --- | --- | --- | --- |
| [P860026](https://fda.innolitics.com/submissions/NE/subpart-f%E2%80%94neurological-therapeutic-devices/GZE/P860026.md) | DIAPHRAGMATIC PACEMAKER PHRENIC NERVE STIMULATOR | Avery Biomedical Devices, Inc. | Jan 5, 1987 | APPR |

## Top Applicants

- Avery Biomedical Devices, Inc. — 1 clearance

---

**Source:** [https://fda.innolitics.com/submissions/NE/subpart-f%E2%80%94neurological-therapeutic-devices/GZE](https://fda.innolitics.com/submissions/NE/subpart-f%E2%80%94neurological-therapeutic-devices/GZE)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com
